SABBY MANAGEMENT, LLC - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 2 filers reported holding TRILLIUM THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SABBY MANAGEMENT, LLC ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$1,229,000
-11.7%
70,000
-51.2%
0.17%
-15.3%
Q2 2021$1,392,000
-35.0%
143,496
-28.1%
0.20%
-53.0%
Q1 2021$2,143,000
-59.3%
199,569
+63.1%
0.42%
-58.7%
Q4 2020$5,265,000
+352.7%
122,375
-57.5%
1.01%
+108.9%
Q1 2020$1,163,000
+787.8%
287,906
+1936.5%
0.48%
+6800.0%
Q1 2016$131,00014,1370.01%
Other shareholders
TRILLIUM THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
NEA Management Company, LLC 2,100,000$646,0000.05%
Matrix Capital Management Company, LP 2,288,560$704,0000.02%
Tekla Capital Management LLC 446,099$137,0000.01%
Realta Investment Advisors 26,000$7,0000.00%
Virtu Financial LLC 34,991$11,0000.00%
Baker Brothers Advisors 505,262$155,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 20,044$6,0000.00%
MORGAN STANLEY 1,160,098$356,0000.00%
BANK OF MONTREAL /CAN/ 18,333$6,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 102,725$31,0000.00%
View complete list of TRILLIUM THERAPEUTICS INC shareholders